While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: RSCOV-CACE2HE
$1,750.00
Ready-to-use cells engineered to stably express the the ACE2 receptor. These cells are susceptible to infection by viruses expressing the SARS virus spike protein, including SARS-CoV2-S pseudotyped lentivirus, so they can be used for neutralization assays and related studies looking at viral binding.
Coming Soon